Synonyms: ANB-011 | dostarlimab-gxly | Jemperli® | TSR-042 | WBP-285
dostarlimab is an approved drug (EMA & FDA (2021))
Compound class:
Antibody
Comment: Dostarlimab is a humanized, IgG4κ programmed cell death 1 (PD-1) blocking monoclonal antibody from GlaxoSmithKline.
|
Bioactivity Comments |
A meeting abstract indicates that dostarlimab has high affinity for both human and cynomolgus monkey PD-1, but does not cross-react with the mouse orthologue, and that it inhibits the interaction of both PD-L1 and PD-L2 with PD-1. |
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|